Global and United States Prescription Gastrointestinal Drugs Market Report & Forecast 2024-2031

Report ID: 1825558 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Prescription Gastrointestinal Drugs Product Introduction
    1.2 Global Prescription Gastrointestinal Drugs Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Prescription Gastrointestinal Drugs Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Prescription Gastrointestinal Drugs Sales in Volume for the Year 2017-2028
    1.3 United States Prescription Gastrointestinal Drugs Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Prescription Gastrointestinal Drugs Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Prescription Gastrointestinal Drugs Sales in Volume for the Year 2017-2028
    1.4 Prescription Gastrointestinal Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Prescription Gastrointestinal Drugs in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Prescription Gastrointestinal Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Prescription Gastrointestinal Drugs Market Dynamics
        1.5.1 Prescription Gastrointestinal Drugs Industry Trends
        1.5.2 Prescription Gastrointestinal Drugs Market Drivers
        1.5.3 Prescription Gastrointestinal Drugs Market Challenges
        1.5.4 Prescription Gastrointestinal Drugs Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Prescription Gastrointestinal Drugs Market Segment by Type
        2.1.1 Oral
        2.1.2 Topical
    2.2 Global Prescription Gastrointestinal Drugs Market Size by Type
        2.2.1 Global Prescription Gastrointestinal Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Prescription Gastrointestinal Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Prescription Gastrointestinal Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Prescription Gastrointestinal Drugs Market Size by Type
        2.3.1 United States Prescription Gastrointestinal Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Prescription Gastrointestinal Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Prescription Gastrointestinal Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Prescription Gastrointestinal Drugs Market Segment by Application
        3.1.1 Hospital Pharmacies
        3.1.2 Online Pharmacies
        3.1.3 Retail Pharmacies
    3.2 Global Prescription Gastrointestinal Drugs Market Size by Application
        3.2.1 Global Prescription Gastrointestinal Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Prescription Gastrointestinal Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Prescription Gastrointestinal Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Prescription Gastrointestinal Drugs Market Size by Application
        3.3.1 United States Prescription Gastrointestinal Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Prescription Gastrointestinal Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Prescription Gastrointestinal Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Prescription Gastrointestinal Drugs Competitor Landscape by Company
    4.1 Global Prescription Gastrointestinal Drugs Market Size by Company
        4.1.1 Top Global Prescription Gastrointestinal Drugs Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Prescription Gastrointestinal Drugs Revenue by Manufacturer (2017-2022)
        4.1.3 Global Prescription Gastrointestinal Drugs Sales by Manufacturer (2017-2022)
        4.1.4 Global Prescription Gastrointestinal Drugs Price by Manufacturer (2017-2022)
    4.2 Global Prescription Gastrointestinal Drugs Concentration Ratio (CR)
        4.2.1 Prescription Gastrointestinal Drugs Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Prescription Gastrointestinal Drugs in 2021
        4.2.3 Global Prescription Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Prescription Gastrointestinal Drugs Manufacturing Base Distribution, Product Type
        4.3.1 Global Prescription Gastrointestinal Drugs Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Prescription Gastrointestinal Drugs Product Type
        4.3.3 Date of International Manufacturers Enter into Prescription Gastrointestinal Drugs Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Prescription Gastrointestinal Drugs Market Size by Company
        4.5.1 Top Prescription Gastrointestinal Drugs Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Prescription Gastrointestinal Drugs Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Prescription Gastrointestinal Drugs Sales by Players (2020, 2021 & 2022)
5 Global Prescription Gastrointestinal Drugs Market Size by Region
    5.1 Global Prescription Gastrointestinal Drugs Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Prescription Gastrointestinal Drugs Market Size in Volume by Region (2017-2028)
        5.2.1 Global Prescription Gastrointestinal Drugs Sales in Volume by Region: 2017-2022
        5.2.2 Global Prescription Gastrointestinal Drugs Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Prescription Gastrointestinal Drugs Market Size in Value by Region (2017-2028)
        5.3.1 Global Prescription Gastrointestinal Drugs Sales in Value by Region: 2017-2022
        5.3.2 Global Prescription Gastrointestinal Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Prescription Gastrointestinal Drugs Market Size YoY Growth 2017-2028
        6.1.2 North America Prescription Gastrointestinal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Prescription Gastrointestinal Drugs Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Prescription Gastrointestinal Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Prescription Gastrointestinal Drugs Market Size YoY Growth 2017-2028
        6.3.2 Europe Prescription Gastrointestinal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Prescription Gastrointestinal Drugs Market Size YoY Growth 2017-2028
        6.4.2 Latin America Prescription Gastrointestinal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Prescription Gastrointestinal Drugs Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Prescription Gastrointestinal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Corporation Information
        7.1.2 AstraZeneca Description and Business Overview
        7.1.3 AstraZeneca Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 AstraZeneca Prescription Gastrointestinal Drugs Products Offered
        7.1.5 AstraZeneca Recent Development
    7.2 Axcan Pharmaceuticals
        7.2.1 Axcan Pharmaceuticals Corporation Information
        7.2.2 Axcan Pharmaceuticals Description and Business Overview
        7.2.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Products Offered
        7.2.5 Axcan Pharmaceuticals Recent Development
    7.3 Eisai
        7.3.1 Eisai Corporation Information
        7.3.2 Eisai Description and Business Overview
        7.3.3 Eisai Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Eisai Prescription Gastrointestinal Drugs Products Offered
        7.3.5 Eisai Recent Development
    7.4 GlaxoSmithKline
        7.4.1 GlaxoSmithKline Corporation Information
        7.4.2 GlaxoSmithKline Description and Business Overview
        7.4.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 GlaxoSmithKline Prescription Gastrointestinal Drugs Products Offered
        7.4.5 GlaxoSmithKline Recent Development
    7.5 Merck
        7.5.1 Merck Corporation Information
        7.5.2 Merck Description and Business Overview
        7.5.3 Merck Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Merck Prescription Gastrointestinal Drugs Products Offered
        7.5.5 Merck Recent Development
    7.6 Salix Pharmaceuticals
        7.6.1 Salix Pharmaceuticals Corporation Information
        7.6.2 Salix Pharmaceuticals Description and Business Overview
        7.6.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Products Offered
        7.6.5 Salix Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Prescription Gastrointestinal Drugs Industry Chain Analysis
    8.2 Prescription Gastrointestinal Drugs Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Prescription Gastrointestinal Drugs Distributors
    8.3 Prescription Gastrointestinal Drugs Production Mode & Process
    8.4 Prescription Gastrointestinal Drugs Sales and Marketing
        8.4.1 Prescription Gastrointestinal Drugs Sales Channels
        8.4.2 Prescription Gastrointestinal Drugs Distributors
    8.5 Prescription Gastrointestinal Drugs Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Prescription Gastrointestinal Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Prescription Gastrointestinal Drugs Market Trends
    Table 3. Prescription Gastrointestinal Drugs Market Drivers
    Table 4. Prescription Gastrointestinal Drugs Market Challenges
    Table 5. Prescription Gastrointestinal Drugs Market Restraints
    Table 6. Global Prescription Gastrointestinal Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Prescription Gastrointestinal Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Prescription Gastrointestinal Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Prescription Gastrointestinal Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Prescription Gastrointestinal Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Prescription Gastrointestinal Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Prescription Gastrointestinal Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Prescription Gastrointestinal Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Prescription Gastrointestinal Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Prescription Gastrointestinal Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Prescription Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Prescription Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Gastrointestinal Drugs as of 2021)
    Table 18. Top Players of Prescription Gastrointestinal Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Prescription Gastrointestinal Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Prescription Gastrointestinal Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Prescription Gastrointestinal Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Prescription Gastrointestinal Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Prescription Gastrointestinal Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Prescription Gastrointestinal Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Prescription Gastrointestinal Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Prescription Gastrointestinal Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Prescription Gastrointestinal Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Prescription Gastrointestinal Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Prescription Gastrointestinal Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Prescription Gastrointestinal Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Prescription Gastrointestinal Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Prescription Gastrointestinal Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Prescription Gastrointestinal Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Prescription Gastrointestinal Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Prescription Gastrointestinal Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Prescription Gastrointestinal Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Prescription Gastrointestinal Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Prescription Gastrointestinal Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Prescription Gastrointestinal Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Prescription Gastrointestinal Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AstraZeneca Corporation Information
    Table 43. AstraZeneca Description and Business Overview
    Table 44. AstraZeneca Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. AstraZeneca Prescription Gastrointestinal Drugs Product
    Table 46. AstraZeneca Recent Development
    Table 47. Axcan Pharmaceuticals Corporation Information
    Table 48. Axcan Pharmaceuticals Description and Business Overview
    Table 49. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Axcan Pharmaceuticals Product
    Table 51. Axcan Pharmaceuticals Recent Development
    Table 52. Eisai Corporation Information
    Table 53. Eisai Description and Business Overview
    Table 54. Eisai Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Eisai Product
    Table 56. Eisai Recent Development
    Table 57. GlaxoSmithKline Corporation Information
    Table 58. GlaxoSmithKline Description and Business Overview
    Table 59. GlaxoSmithKline Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. GlaxoSmithKline Product
    Table 61. GlaxoSmithKline Recent Development
    Table 62. Merck Corporation Information
    Table 63. Merck Description and Business Overview
    Table 64. Merck Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Merck Product
    Table 66. Merck Recent Development
    Table 67. Salix Pharmaceuticals Corporation Information
    Table 68. Salix Pharmaceuticals Description and Business Overview
    Table 69. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Salix Pharmaceuticals Product
    Table 71. Salix Pharmaceuticals Recent Development
    Table 72. Key Raw Materials Lists
    Table 73. Raw Materials Key Suppliers Lists
    Table 74. Prescription Gastrointestinal Drugs Customers List
    Table 75. Prescription Gastrointestinal Drugs Distributors List
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Prescription Gastrointestinal Drugs Product Picture
    Figure 2. Global Prescription Gastrointestinal Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Prescription Gastrointestinal Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Prescription Gastrointestinal Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Prescription Gastrointestinal Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Prescription Gastrointestinal Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Prescription Gastrointestinal Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Prescription Gastrointestinal Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Prescription Gastrointestinal Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Prescription Gastrointestinal Drugs Report Years Considered
    Figure 11. Product Picture of Oral
    Figure 12. Product Picture of Topical
    Figure 13. Global Prescription Gastrointestinal Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Prescription Gastrointestinal Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Prescription Gastrointestinal Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Prescription Gastrointestinal Drugs Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Prescription Gastrointestinal Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Prescription Gastrointestinal Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Prescription Gastrointestinal Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Prescription Gastrointestinal Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Prescription Gastrointestinal Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Prescription Gastrointestinal Drugs Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Prescription Gastrointestinal Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Prescription Gastrointestinal Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Hospital Pharmacies
    Figure 26. Product Picture of Online Pharmacies
    Figure 27. Product Picture of Retail Pharmacies
    Figure 28. Global Prescription Gastrointestinal Drugs Market Share by Application in 2022 & 2028
    Figure 29. Global Prescription Gastrointestinal Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Prescription Gastrointestinal Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Prescription Gastrointestinal Drugs Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Prescription Gastrointestinal Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Prescription Gastrointestinal Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Prescription Gastrointestinal Drugs Market Share by Application in 2022 & 2028
    Figure 35. United States Prescription Gastrointestinal Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Prescription Gastrointestinal Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Prescription Gastrointestinal Drugs Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Prescription Gastrointestinal Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Prescription Gastrointestinal Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Prescription Gastrointestinal Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Prescription Gastrointestinal Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Prescription Gastrointestinal Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Prescription Gastrointestinal Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Prescription Gastrointestinal Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Prescription Gastrointestinal Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Prescription Gastrointestinal Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Prescription Gastrointestinal Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Prescription Gastrointestinal Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Prescription Gastrointestinal Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Prescription Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Prescription Gastrointestinal Drugs Value Chain
    Figure 74. Prescription Gastrointestinal Drugs Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Axcan Pharmaceuticals
Eisai
GlaxoSmithKline
Merck
Salix Pharmaceuticals
Frequently Asked Questions
Prescription Gastrointestinal Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prescription Gastrointestinal Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prescription Gastrointestinal Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports